Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

The conclusion is that certain scalp tissue changes are characteristic of lichen planopilaris, with mucinous perifollicular fibroplasia being a new feature for diagnosis.

Some women with common hair loss may develop permanent hair loss.

CCCA is a scarring hair loss condition mainly in African descent women, possibly caused by genetics and hairstyling, treated with gentle hair care and medications.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

Dermoscopy improves diagnosis and treatment monitoring for children's skin infections, inflammations, and hair disorders.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

Minoxidil and pyrithione zinc combo most effectively increases hair density.

Skin tumor regression is helped by retinoic acid signaling blocking Wnt signaling.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.

Men with Frontal fibrosing alopecia typically lose hair on the front scalp and sometimes on sideburns and upper lip, with treatments showing varied success.

Pseudopelade of Brocq is a unique hair loss condition, but its cause and development are still not fully understood.

Black women's unique hair characteristics and styling practices can lead to specific scalp conditions, which require early diagnosis and appropriate treatment.

Frontal fibrosing alopecia can cause sudden hair loss on limbs, similar to scalp hair loss.

The document concludes that accurate diagnosis and treatment of scalp itch require differentiating between various conditions using a proposed five-step evaluation process.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

A rare skin rash after COVID-19 vaccination shouldn't stop future vaccinations.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

No treatment has been proven to effectively stop hair loss or regrow hair in Frontal Fibrosing Alopecia, and more research is needed.

Managing frontal fibrosing alopecia and lichen planus pigmentosus is challenging due to resistant hair loss and skin discoloration.

The document concludes that new methods improve the accuracy of diagnosing scalp alopecia and challenges the old way of classifying it.

The document concludes that mesotherapy can be effective for skin and hair treatments, but more research is needed to confirm its safety and effectiveness.

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.

Minoxidil can cause deadly skin reaction; monitor patients closely.

The new mild shampoo helped prevent hair loss in the subjects.

Cutting scalp biopsies in consecutive slices improves diagnosis of hair loss conditions.

Most HIV patients develop skin symptoms that can indicate the stage of their disease.